GCSAML

gene
On this page

Also known as FLJ44728

Summary

GCSAML (germinal center associated signaling and motility like, HGNC:29583) is a protein-coding gene on chromosome 1q44, encoding Germinal center-associated signaling and motility-like protein (Q5JQS6).

This gene encodes a protein thought to be a signaling molecule associated with germinal centers, the sites of proliferation and differentiation of mature B lymphocytes. Alternate splicing results in multiple transcript variants.

Source: NCBI Gene 148823 — RefSeq curated summary.

At a glance

  • GWAS associations: 25
  • Clinical variants (ClinVar): 71 total — 1 pathogenic
  • MANE Select transcript: NM_145278

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29583
Approved symbolGCSAML
Namegerminal center associated signaling and motility like
Location1q44
Locus typegene with protein product
StatusApproved
AliasesFLJ44728
Ensembl geneENSG00000169224
Ensembl biotypeprotein_coding
Entrez148823

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 10 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000366488, ENST00000366489, ENST00000366491, ENST00000463359, ENST00000526896, ENST00000527084, ENST00000527541, ENST00000529512, ENST00000531662, ENST00000536561, ENST00000623578

RefSeq mRNA: 7 — MANE Select: NM_145278 NM_001281834, NM_001281835, NM_001281836, NM_001281837, NM_001281838, NM_001281853, NM_145278

CCDS: CCDS1635, CCDS60470, CCDS73058

Canonical transcript exons

ENST00000366488 — 5 exons

ExonStartEnd
ENSE00001441828247574143247577690
ENSE00001742146247565931247565959
ENSE00002186018247549134247549220
ENSE00003502756247556407247556466
ENSE00003681324247563590247563639

Expression profiles

Bgee: expression breadth ubiquitous, 149 present calls, max score 92.46.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 15.9501 / max 14238.0199, expressed in 139 samples.

FANTOM5 promoters (11 alternative TSS)

Promoter IDTPM avgSamples expressed
962112.9400121
96202.305748
96220.353327
96190.171034
96180.088511
96160.025113
2020430.02388
96170.01636
2020440.01485
96130.00793

Top tissues by expression

239 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
buccal mucosa cellCL:000233692.46gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.79gold quality
monocyteCL:000057674.96gold quality
leukocyteCL:000073874.03gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099170.27gold quality
right testisUBERON:000453469.57gold quality
left testisUBERON:000453369.27gold quality
testisUBERON:000047368.64gold quality
cerebellar hemisphereUBERON:000224568.21gold quality
cerebellar cortexUBERON:000212968.13gold quality
cerebellumUBERON:000203767.62gold quality
bone marrow cellCL:000209265.94silver quality
prostate glandUBERON:000236765.24gold quality
right hemisphere of cerebellumUBERON:001489064.29gold quality
gall bladderUBERON:000211064.16gold quality
smooth muscle tissueUBERON:000113562.66gold quality
rectumUBERON:000105262.26gold quality
colonic epitheliumUBERON:000039761.49gold quality
vermiform appendixUBERON:000115459.69gold quality
lower esophagus muscularis layerUBERON:003583357.91gold quality
lower esophagusUBERON:001347357.86gold quality
esophagogastric junction muscularis propriaUBERON:003584157.52gold quality
bloodUBERON:000017856.72gold quality
upper lobe of left lungUBERON:000895256.39gold quality
right lungUBERON:000216755.89gold quality
upper lobe of lungUBERON:000894855.89gold quality
cerebellar vermisUBERON:000472055.74gold quality
caecumUBERON:000115355.41gold quality
cortical plateUBERON:000534354.67silver quality
right coronary arteryUBERON:000162554.12gold quality

Single-cell (SCXA)

Detected in 8 experiment(s), a significant marker in 7.

ExperimentMarker?Max mean expression
E-HCAD-29yes3173.49
E-MTAB-6678yes697.48
E-ANND-3yes16.01
E-MTAB-9067yes11.53
E-GEOD-130148yes7.47
E-HCAD-10yes7.01
E-MTAB-9801yes6.33
E-CURD-112no2.95

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

118 targeting GCSAML, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6798-5P100.0065.77699
HSA-MIR-3064-3P100.0070.091254
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-8485100.0077.574731
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-656-3P100.0072.152788
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-428299.9975.366408
HSA-MIR-548AW99.9972.573559
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-477599.9875.006394
HSA-MIR-1185-1-3P99.9871.042593
HSA-MIR-1185-2-3P99.9871.042593
HSA-LET-7F-2-3P99.9870.982588
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-56899.9869.862084
HSA-MIR-4482-3P99.9872.503147
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-590-3P99.9674.346478
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-548AE-3P99.9372.664867
HSA-MIR-548AH-3P99.9372.544872
HSA-MIR-548AM-3P99.9372.544872
HSA-MIR-548AQ-3P99.9372.664867
HSA-MIR-6508-5P99.9270.672465

Literature-anchored findings (GeneRIF, showing 1)

  • Maternal 5mCpG imprints at the GCSAML somatic (secondary) differentially methylated region (iDMR) are decoupled from parent-of-origin expression effects in multiple human tissues. Despite the constitutive methylation asymmetry observed for the parental alleles at the iDMR, GCSAML was expressed biallelically in five tissues: visceral adipose tissue, brain - cerebellar hemisphere, brain cerebellum, prostate, and testis. (PMID:29545821)

Cross-species orthologs

0 orthologs

Paralogs (1): GCSAM (ENSG00000174500)

Protein

Protein identifiers

Germinal center-associated signaling and motility-like proteinQ5JQS6 (reviewed: Q5JQS6)

All UniProt accessions (4): Q5JQS6, E9PLW0, E9PR51, E9PRX8

Isoforms (2)

UniProt IDNamesCanonical?
Q5JQS6-11yes
Q5JQS6-22

RefSeq proteins (7): NP_001268763, NP_001268764, NP_001268765, NP_001268766, NP_001268767, NP_001268782, NP_660321* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR031364GC_assoc_lymFamily

Pfam: PF15666

UniProt features (6 total): compositionally biased region 2, chain 1, region of interest 1, coiled-coil region 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5JQS6-F166.660.01

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 69 (showing top): GOBP_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY, GOBP_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY, GOBP_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY, GOBP_REGULATION_OF_LEUKOCYTE_MIGRATION, GOBP_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION, GOBP_LEUKOCYTE_MIGRATION, GOBP_REGULATION_OF_IMMUNE_RESPONSE, GOBP_LYMPHOCYTE_MIGRATION, chr1q44, GOBP_B_CELL_RECEPTOR_SIGNALING_PATHWAY, GOBP_REGULATION_OF_LYMPHOCYTE_MIGRATION, GOBP_ACTIVATION_OF_IMMUNE_RESPONSE, WIERENGA_STAT5A_TARGETS_DN, GOBP_IMMUNE_RESPONSE_REGULATING_SIGNALING_PATHWAY, GOBP_MONONUCLEAR_CELL_MIGRATION

GO Biological Process (2): regulation of B cell receptor signaling pathway (GO:0050855), regulation of lymphocyte migration (GO:2000401)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
B cell receptor signaling pathway1
regulation of antigen receptor-mediated signaling pathway1
regulation of mononuclear cell migration1
lymphocyte migration1
binding1

Protein interactions and networks

STRING

334 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
GCSAMLSEZ6LQ9BYH1531
GCSAMLSAMD12Q8N8I0489
GCSAMLCALHM3Q86XJ0477
GCSAMLMTMR8Q96EF0438
GCSAMLOR2C3Q8N628432
GCSAMLZNF71Q9NQZ8429
GCSAMLE9PNW1E9PNW1419
GCSAMLPTPREP23469417
GCSAMLDHRS13Q6UX07413
GCSAMLCSTPP1Q9H6J7400
GCSAMLCLVS1Q8IUQ0396
GCSAMLCCDC71LQ8N9Z2396
GCSAMLTMTC2Q8N394375
GCSAMLKLHDC8BQ8IXV7373
GCSAMLGAL3ST4Q96RP7370
GCSAMLLONRF3Q496Y0370

IntAct

23 interactions, top by confidence:

ABTypeScore
PRKAB2GCSAMLpsi-mi:“MI:0915”(physical association)0.560
STAMBPL1GCSAMLpsi-mi:“MI:0915”(physical association)0.560
GCSAMLNTAQ1psi-mi:“MI:0915”(physical association)0.560
GCSAMLEAF1psi-mi:“MI:0915”(physical association)0.560
GCSAMLSTAMBPL1psi-mi:“MI:0915”(physical association)0.560
GCSAMLUBL5psi-mi:“MI:0915”(physical association)0.560
GCSAMLEIF1ADpsi-mi:“MI:0915”(physical association)0.560
GCSAMLFAM90A1psi-mi:“MI:0915”(physical association)0.560
GCSAMLSPAG9psi-mi:“MI:0914”(association)0.350
NTAQ1GCSAMLpsi-mi:“MI:0915”(physical association)0.000
EAF1GCSAMLpsi-mi:“MI:0915”(physical association)0.000
UBL5GCSAMLpsi-mi:“MI:0915”(physical association)0.000
EIF1ADGCSAMLpsi-mi:“MI:0915”(physical association)0.000
FAM90A1GCSAMLpsi-mi:“MI:0915”(physical association)0.000
GCSAMLEIF1ADpsi-mi:“MI:0915”(physical association)0.000

BioGRID (12): GCSAML (Two-hybrid), GCSAML (Two-hybrid), GCSAML (Two-hybrid), GCSAML (Two-hybrid), FAM90A1 (Two-hybrid), EIF1AD (Two-hybrid), UBL5 (Two-hybrid), SASS6 (Affinity Capture-MS), PLXDC2 (Affinity Capture-MS), MARS2 (Affinity Capture-MS), SPAG9 (Affinity Capture-MS), ZMYM6 (Affinity Capture-MS)

ESM2 similar proteins: A0JNM1, D3Z1Q2, P16871, P20963, P24161, P29329, P59773, Q16655, Q29102, Q2KIP5, Q2YDG7, Q3SYX1, Q3U1F9, Q3UU41, Q3UU67, Q4W815, Q5DTU0, Q5E9I3, Q5JQS6, Q6ITQ4, Q6PF55, Q6PIZ9, Q6RFH4, Q6UWF3, Q6XQ84, Q6ZUJ8, Q6ZWK4, Q80VH0, Q80WK2, Q86UW2, Q8C115, Q8C4Q9, Q8CB93, Q8N292, Q8N4X5, Q8N6F7, Q8NDB2, Q8NEA5, Q90479, Q90VY2

Diamond homologs: Q5JQS6, Q6RFH4, Q8N6F7

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

71 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance63
Likely benign1
Benign1

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
253547GRCh37/hg19 1q43-44(chr1:243103401-249119318)x1Pathogenic

SpliceAI

1595 predictions. Top by Δscore:

VariantEffectΔscore
1:247507229:GCTGG:Gdonor_gain1.0000
1:247507232:GG:Gdonor_gain1.0000
1:247507233:GG:Gdonor_gain1.0000
1:247556392:T:Gacceptor_gain1.0000
1:247556392:T:TAacceptor_gain1.0000
1:247556402:T:Gacceptor_gain1.0000
1:247556405:A:AGacceptor_gain1.0000
1:247556406:G:GAacceptor_gain1.0000
1:247556406:GTT:Gacceptor_gain1.0000
1:247556463:AACGG:Adonor_loss1.0000
1:247556464:ACGG:Adonor_loss1.0000
1:247556465:CGGT:Cdonor_loss1.0000
1:247556466:GGTA:Gdonor_loss1.0000
1:247556467:G:GGdonor_gain1.0000
1:247556468:T:TCdonor_loss1.0000
1:247563586:GTA:Gacceptor_loss1.0000
1:247563588:A:AGacceptor_gain1.0000
1:247563589:G:GAacceptor_loss1.0000
1:247563589:G:GGacceptor_gain1.0000
1:247563589:GGCA:Gacceptor_gain1.0000
1:247563635:GAAAA:Gdonor_gain1.0000
1:247563636:AAAA:Adonor_gain1.0000
1:247563637:AAA:Adonor_gain1.0000
1:247563638:AA:Adonor_gain1.0000
1:247563639:AGTAA:Adonor_loss1.0000
1:247563640:G:GGdonor_gain1.0000
1:247563641:T:Gdonor_loss1.0000
1:247565921:A:AGacceptor_gain1.0000
1:247507230:CTGG:Cdonor_gain0.9900
1:247507230:CTGGG:Cdonor_loss0.9900

AlphaMissense

897 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:247574302:T:CY110H0.975
1:247574303:A:CY110S0.967
1:247574179:T:GY69D0.956
1:247574247:C:AN91K0.954
1:247574247:C:GN91K0.954
1:247574302:T:GY110D0.951
1:247574305:G:CA111P0.948
1:247574303:A:GY110C0.946
1:247549195:G:AG2R0.922
1:247549195:G:CG2R0.922
1:247574302:T:AY110N0.915
1:247574243:A:TE90V0.914
1:247574179:T:AY69N0.912
1:247574309:T:CL112P0.909
1:247574239:T:CY89H0.907
1:247574240:A:CY89S0.902
1:247574239:T:GY89D0.901
1:247574179:T:CY69H0.900
1:247574180:A:CY69S0.894
1:247574297:C:TT108I0.894
1:247574244:G:CE90D0.883
1:247574244:G:TE90D0.883
1:247574246:A:TN91I0.883
1:247574306:C:AA111D0.883
1:247574189:T:GI72S0.880
1:247549196:G:TG2V0.873
1:247574243:A:CE90A0.856
1:247574312:T:CL113P0.854
1:247574246:A:CN91T0.851
1:247574189:T:AI72N0.845

dbSNP variants (sampled 300 via entrez): RS1000005905 (1:247531025 G>C,T), RS1000103261 (1:247566238 TTTTA>T,TTTTATTTA), RS1000125380 (1:247521393 C>T), RS1000196447 (1:247554026 C>T), RS1000236980 (1:247524698 T>G), RS1000317203 (1:247510095 A>G), RS1000375794 (1:247561063 C>T), RS1000392243 (1:247560718 T>A,C), RS1000426751 (1:247556723 G>A,C), RS1000486732 (1:247513286 TC>T), RS1000509842 (1:247519696 T>C), RS1000591061 (1:247508815 G>A), RS1000602193 (1:247568461 G>A,T), RS1000610833 (1:247526153 T>G), RS1000622063 (1:247509061 G>C,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

25 associations (top):

StudyTraitp-value
GCST004599_265Mean platelet volume3.000000e-54
GCST004599_266Mean platelet volume1.000000e-60
GCST004603_202Platelet count2.000000e-54
GCST004603_203Platelet count3.000000e-86
GCST004607_210Plateletcrit9.000000e-23
GCST004607_211Plateletcrit4.000000e-43
GCST004616_123Platelet distribution width1.000000e-47
GCST004616_124Platelet distribution width5.000000e-75
GCST004619_63Reticulocyte fraction of red cells8.000000e-15
GCST004622_143Reticulocyte count1.000000e-17
GCST006101_11Cardiometabolic and hematological traits3.000000e-34
GCST010122_2Ceramide levels (C22:0)6.000000e-06
GCST90002385_111High light scatter reticulocyte count2.000000e-11
GCST90002392_260Mean corpuscular volume5.000000e-11
GCST90002395_513Mean platelet volume4.000000e-59
GCST90002395_514Mean platelet volume2.000000e-131
GCST90002397_758Mean spheric corpuscular volume4.000000e-17
GCST90002400_549Plateletcrit1.000000e-13
GCST90002400_550Plateletcrit1.000000e-61
GCST90002401_411Platelet distribution width1.000000e-50
GCST90002401_412Platelet distribution width7.000000e-134
GCST90002402_270Platelet count8.000000e-42
GCST90002402_271Platelet count1.000000e-151
GCST90002405_103Reticulocyte count1.000000e-20
GCST90002406_125Reticulocyte fraction of red cells7.000000e-18

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0004309platelet count
EFO:0007985platelet crit
EFO:0007984platelet component distribution width
EFO:0007986reticulocyte count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

10 total (human), top 10 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects methylation, affects cotreatment, increases methylation1
di-n-butylphosphoric acidaffects expression1
bisphenol Saffects cotreatment, increases methylation, decreases methylation1
Fulvestrantaffects cotreatment, increases methylation1
Benzo(a)pyreneaffects methylation1
Hydralazineincreases expression, affects cotreatment1
Methotrexateincreases expression1
Niclosamidedecreases expression1
Valproic Acidincreases expression, affects cotreatment1
Aflatoxin B1increases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.